In pancreatic cancer, ablation of SETD2 caused the deletion of CTNNA1, thereby mediating the enhancement of EMT, which strongly suggests that CTNNA1 plays a role in suppressing EMT. This evidence concerns the gene SETD2 and familial pancreatic carcinoma.